SWOT Analysis for Eris Lifesciences Ltd.

Benjamin Graham Value Screen
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Upcoming results for Nifty500 companies with previous quarter net profit growth greater than 10% YoY and QoQ
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Companies with decreasing Promoter pledge
Near 52 Week High
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding
Companies with growing costs YoY for long term projects
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Declining Revenue every quarter for the past 2 quarters
Companies Increasing Debt as per Annual Report
Increasing Trend in Non-Core Income
High promoter stock pledges
Top Losers
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Companies with Upcoming Results
Brokers upgraded recommendation or target price in the past three months
Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months

Bullish or Bearish Candlestick Strength - Indices
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Eris Lifesciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats